Clinical Trials Clinical Studies National Institutes of Health Epidemiological Studies Animal Models Cancer Research Funding Drug Development Vaccine Development Immunology
This program has validated de novo proteins that target antibiotic-resistant E. coli, paving faster, more affordable development of new therapeutics.